Overview
DGX market data
Price History
DGX price chart
Valuation & Profitability
- P/E (TTM)
- 24.62 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $8.78 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.53 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.5% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 9.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $171.18 – $240.13 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $26.1B · P/B 2.69 · P/S 2.26.
Company News
JP Morgan Maintains Neutral on Quest Diagnostics, Raises Price Target to $250Benzinga · Jul 28, 2026, 1:48 PM
Mizuho Maintains Outperform on Quest Diagnostics, Raises Price Target to $260Benzinga · Jul 24, 2026, 6:41 PM
Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $250Benzinga · Jul 24, 2026, 6:08 PM
Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $250Benzinga · Jul 24, 2026, 3:08 PM
Baird Maintains Neutral on Quest Diagnostics, Raises Price Target to $255Benzinga · Jul 24, 2026, 11:33 AM
Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is WinningBenzinga · Jul 23, 2026, 5:47 PM
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On ThursdayBenzinga · Jul 23, 2026, 2:20 PM
Transcript: Quest Diagnostics Q2 2026 Earnings Conference CallBenzinga · Jul 23, 2026, 1:33 PM
Quest Diagnostics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance above estimates.Benzinga · Jul 23, 2026, 12:43 PM
Earnings Scheduled For July 23, 2026Benzinga · Jul 23, 2026, 11:11 AM